Cargando…

Artificial Intelligence in Reproductive Medicine – An Ethical Perspective

Artificial intelligence is steadily being integrated into all areas of medicine. In reproductive medicine, artificial intelligence methods can be utilized to improve the selection and prediction of sperm cells, oocytes, and embryos and to generate better predictive models for in vitro fertilization....

Descripción completa

Detalles Bibliográficos
Autores principales: Rolfes, Vasilija, Bittner, Uta, Gerhards, Helene, Krüssel, Jan-Steffen, Fehm, Tanja, Ranisch, Robert, Fangerau, Heiner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833891/
https://www.ncbi.nlm.nih.gov/pubmed/36643877
http://dx.doi.org/10.1055/a-1866-2792
_version_ 1784868337708171264
author Rolfes, Vasilija
Bittner, Uta
Gerhards, Helene
Krüssel, Jan-Steffen
Fehm, Tanja
Ranisch, Robert
Fangerau, Heiner
author_facet Rolfes, Vasilija
Bittner, Uta
Gerhards, Helene
Krüssel, Jan-Steffen
Fehm, Tanja
Ranisch, Robert
Fangerau, Heiner
author_sort Rolfes, Vasilija
collection PubMed
description Artificial intelligence is steadily being integrated into all areas of medicine. In reproductive medicine, artificial intelligence methods can be utilized to improve the selection and prediction of sperm cells, oocytes, and embryos and to generate better predictive models for in vitro fertilization. The use of artificial intelligence in this field is justified by the suffering of persons or couples who wish to have children but are unable to conceive. However, research into the use of artificial intelligence in reproductive medicine is still in the early experimental stage and furthermore raises complex normative questions. There are ethical research challenges because evidence of the efficacy of certain pertinent systems is often lacking and because of the increased difficulty of ensuring informed consent on the part of the affected persons. Other ethically relevant issues include the potential risks for offspring and the difficulty of providing sufficient information. The opportunity to fulfill the desire to have children affects the welfare of patients and their reproductive autonomy. Ultimately, ensuring more accurate predictions and allowing physicians to devote more time to their patients will have a positive effect. Nevertheless, clinicians must be able to process patient data conscientiously. When using artificial intelligence, numerous actors are involved in making the diagnosis and deciding on the appropriate therapy, raising questions about who is ultimately responsible when mistakes occur. Questions of fairness arise with regard to resource allocation and cost reimbursement. Thus, before implementing artificial intelligence in clinical practice, it is necessary to critically examine the quantity and quality of the data used and to address issues of transparency. In the medium and long term, it would be necessary to confront the undesirable impact and social dynamics that may accompany the use of artificial intelligence in reproductive medicine.
format Online
Article
Text
id pubmed-9833891
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-98338912023-01-12 Artificial Intelligence in Reproductive Medicine – An Ethical Perspective Rolfes, Vasilija Bittner, Uta Gerhards, Helene Krüssel, Jan-Steffen Fehm, Tanja Ranisch, Robert Fangerau, Heiner Geburtshilfe Frauenheilkd Artificial intelligence is steadily being integrated into all areas of medicine. In reproductive medicine, artificial intelligence methods can be utilized to improve the selection and prediction of sperm cells, oocytes, and embryos and to generate better predictive models for in vitro fertilization. The use of artificial intelligence in this field is justified by the suffering of persons or couples who wish to have children but are unable to conceive. However, research into the use of artificial intelligence in reproductive medicine is still in the early experimental stage and furthermore raises complex normative questions. There are ethical research challenges because evidence of the efficacy of certain pertinent systems is often lacking and because of the increased difficulty of ensuring informed consent on the part of the affected persons. Other ethically relevant issues include the potential risks for offspring and the difficulty of providing sufficient information. The opportunity to fulfill the desire to have children affects the welfare of patients and their reproductive autonomy. Ultimately, ensuring more accurate predictions and allowing physicians to devote more time to their patients will have a positive effect. Nevertheless, clinicians must be able to process patient data conscientiously. When using artificial intelligence, numerous actors are involved in making the diagnosis and deciding on the appropriate therapy, raising questions about who is ultimately responsible when mistakes occur. Questions of fairness arise with regard to resource allocation and cost reimbursement. Thus, before implementing artificial intelligence in clinical practice, it is necessary to critically examine the quantity and quality of the data used and to address issues of transparency. In the medium and long term, it would be necessary to confront the undesirable impact and social dynamics that may accompany the use of artificial intelligence in reproductive medicine. Georg Thieme Verlag KG 2023-01-11 /pmc/articles/PMC9833891/ /pubmed/36643877 http://dx.doi.org/10.1055/a-1866-2792 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Rolfes, Vasilija
Bittner, Uta
Gerhards, Helene
Krüssel, Jan-Steffen
Fehm, Tanja
Ranisch, Robert
Fangerau, Heiner
Artificial Intelligence in Reproductive Medicine – An Ethical Perspective
title Artificial Intelligence in Reproductive Medicine – An Ethical Perspective
title_full Artificial Intelligence in Reproductive Medicine – An Ethical Perspective
title_fullStr Artificial Intelligence in Reproductive Medicine – An Ethical Perspective
title_full_unstemmed Artificial Intelligence in Reproductive Medicine – An Ethical Perspective
title_short Artificial Intelligence in Reproductive Medicine – An Ethical Perspective
title_sort artificial intelligence in reproductive medicine – an ethical perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833891/
https://www.ncbi.nlm.nih.gov/pubmed/36643877
http://dx.doi.org/10.1055/a-1866-2792
work_keys_str_mv AT rolfesvasilija artificialintelligenceinreproductivemedicineanethicalperspective
AT bittneruta artificialintelligenceinreproductivemedicineanethicalperspective
AT gerhardshelene artificialintelligenceinreproductivemedicineanethicalperspective
AT krusseljansteffen artificialintelligenceinreproductivemedicineanethicalperspective
AT fehmtanja artificialintelligenceinreproductivemedicineanethicalperspective
AT ranischrobert artificialintelligenceinreproductivemedicineanethicalperspective
AT fangerauheiner artificialintelligenceinreproductivemedicineanethicalperspective